GlassScriptPhysician profile
Michael B Hamilton
NPI 1548594716
$2,193.21
in general payments reported to CMS, 2019-2025
11 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $566 · 2022: $1,133 · 2023: $262 · 2024: $104 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,358.60 | 2021-2024 | Senza |
| Vertos Medical, INC. | $552.11 | 2021-2023 | Mild Device Kit |
| Globus Medical, INC. | $128.97 | 2025 | Senza, Vyrsa V1 |
| Collegium Pharmaceutical, INC. | $28.50 | 2021 | |
| Pacira Therapeutics, INC. | $23.63 | 2021 | |
| Scilex Pharmaceuticals INC. | $23.15 | 2024 | |
| Gilead Sciences, INC. | $19.10 | 2023 | Epclusa |
| Spr Therapeutics, INC | $18.11 | 2024 | Sprint Pns System |
| Uswm, LLC | $17.17 | 2021 | |
| Biodelivery Sciences International, INC. | $12.10 | 2021 | |
| Indivior INC. | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.